Brivaracetam

Known as: (2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide, 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-, 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
0204019962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
This phase I, open-label study investigated the effects of steady-state brivaracetam administration on steady-state… (More)
Is this relevant?
2015
2015
We evaluated nonpsychotic behavioral adverse events (BAEs) in patients receiving levetiracetam (LEV) who switched to brivaracetam… (More)
  • table 1
  • table 3
  • table 2
Is this relevant?
2014
2014
Brivaracetam is a high-affinity synaptic vesicle protein 2A ligand, in phase 3 clinical development for epilepsy. A phase 1… (More)
Is this relevant?
2014
2014
PURPOSE Brivaracetam (BRV) is a novel high-affinity synaptic vesicle protein 2A ligand in clinical development for the treatment… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2012
2012
Brivaracetam is a novel high-affinity SV2A ligand currently in clinical development for epilepsy. The objective was to… (More)
  • figure 1
Is this relevant?
2011
2011
Brivaracetam is a novel synaptic vesicle protein 2A (SV2A) ligand reported to be 10 fold more potent than levetiracetam in animal… (More)
Is this relevant?
2011
2011
PURPOSE Brivaracetam (BRV) is a new anticonvulsant under development. Although BRV is an analog of levetiracetam (LEV), in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
OBJECTIVE To explore efficacy and safety/tolerability of adjunctive brivaracetam (BRV), a novel, high-affinity synaptic vesicle… (More)
Is this relevant?
2008
2008
Levetiracetam, the alpha-ethyl analogue of the nootropic piracetam, is a widely used antiepileptic drug (AED) that provides… (More)
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND AND PURPOSE Screening of 12,000 compounds for binding affinity to the synaptic vesicle protein 2A (SV2A), identified a… (More)
Is this relevant?